0001628280-22-000068.txt : 20220103 0001628280-22-000068.hdr.sgml : 20220103 20220103161613 ACCESSION NUMBER: 0001628280-22-000068 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220101 FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malievskaia Ekaterina CENTRAL INDEX KEY: 0001898326 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39522 FILM NUMBER: 22502295 MAIL ADDRESS: STREET 1: C/O COMPASS PATHWAYS PLC, 3RD FLOOR STREET 2: 1 ASHLEY ROAD, ALTRINCHAM CITY: CHESHIRE STATE: X0 ZIP: WA14 2DT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COMPASS Pathways plc CENTRAL INDEX KEY: 0001816590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3RD FLOOR, 1 ASHLEY ROAD STREET 2: ALTRINCHAM CITY: CHESIRE STATE: X0 ZIP: WA14 2DT BUSINESS PHONE: 1-646-905-3974 MAIL ADDRESS: STREET 1: 3RD FLOOR, 1 ASHLEY ROAD STREET 2: ALTRINCHAM CITY: CHESIRE STATE: X0 ZIP: WA14 2DT FORMER COMPANY: FORMER CONFORMED NAME: Compass Rx Ltd. DATE OF NAME CHANGE: 20200701 3 1 wf-form3_164124452832692.xml FORM 3 X0206 3 2022-01-01 0 0001816590 COMPASS Pathways plc CMPS 0001898326 Malievskaia Ekaterina COMPASS PATHWAYS PLC 33 BROADWICK STREET LONDON X0 W1F 0DQ UNITED KINGDOM 0 1 0 0 Chief Innovation Officer Ordinary Shares 4261569 D Ordinary Shares 4261573 I By: Spouse Share Option (Right to Buy) 17.0 2030-09-18 Ordinary Shares 85200.0 D Share Option (Right to Buy) 17.0 2030-09-18 Ordinary Shares 113600.0 I By: Spouse The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Includes 44,710 Restricted Share Units ("RSUs") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. 25% of the RSUs vested on August 12, 2021, with the remainder vesting in twelve equal quarterly installments thereafter. Securities held by George Goldsmith, the Reporting Person's spouse. Mr. Goldsmith and Dr. Malievskaia are married but they expressly disclaim beneficial ownership of each other's shares in the Company. 25% of the shares underlying this option vested and became exercisable on September 18, 2021, with the remainder vesting in thirty-six equal monthly installments thereafter. Exhibit 24 - Power of Attorney /s/ Daniel Maalo by Power of Attorney for Ekaterina Malievskaia 2022-01-03 EX-24 2 ex-24.htm MALIEVSKAIA POA

LIMITED POWER OF ATTORNEY
The undersigned hereby constitutes and appoints each of George Goldsmith, Michael Falvey and Daniel Maalo, signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1)execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of COMPASS Pathways plc (the "Company"), from time to time the following U.S. Securities and Exchange Commission ("SEC") forms: (i) Form ID, including any attached documents (such as Update Passphrase Authentication), to effect the assignment of codes to the undersigned to be used in the transmission of information to the SEC using the EDGAR System; (ii) Form 3, Initial Statement of Beneficial Ownership of Securities, including any attached documents; (iii) Form 4, Statement of Changes in Beneficial Ownership of Securities, including any attached documents; (iv) Form 5, Annual Statement of Beneficial Ownership of Securities in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder, including any attached documents; (v) Schedules 13D and 13G; and (vi) amendments of each thereof, in accordance with the Securities Exchange Act of 1934, as amended, and the rules thereunder, including any attached documents;

(2)do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4 or 5, Schedule 13D or 13G, or any amendment(s) thereto and timely file such form(s) with the SEC and any securities exchange, national association or similar authority; and

    (3)    take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact, acting singly, full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 or Regulation 13D-G of the Securities Exchange Act of 1934, as amended.  The undersigned hereby agrees to indemnify the attorneys-in-fact and the Company from and against any demand, damage, loss, cost or expense arising from any false or misleading information provided by the undersigned to the attorneys-in-fact.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file such forms with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.  This Power of Attorney supersedes any prior power of attorney in connection with the undersigned's capacity as an officer and/or director of the Company.  This Power of Attorney shall expire as to any individual attorney-in-fact if such attorney-in-fact ceases to be an employee of the Company.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of
November 24, 2021.

/s/ Ekaterina Malievskaia
_________________________
Ekaterina Malievskaia